Maternal phenylketonuria collaborative study (MPKUCS) offspring: Facial anomalies, malformations, and early neurological sequelae

American Journal of Medical Genetics

Volumn 69, Issue 1, 1997, Pages 89-95

  Rouse, Bobbye ^a   Azen, Colleen ^b   Koch, Richard ^b   Matalon, Reuben ^c,d   Hanley, William ^e   De La Cruz, Felix ^f   Trefz, Friedrich ^g   Friedman, Eva ^b   Shifrin, Harvey ^f  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d MIAMI CHILDREN'S HOSPITAL   (United States)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^g UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

congenital heart disease; facial dysmorphology; maternal phenylketonuria; microcephaly; MPKU

Indexed keywords

PHENYLALANINE;

ARTICLE; CONGENITAL HEART DISEASE; FACE MALFORMATION; HUMAN; INBORN ERROR OF METABOLISM; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MENTAL RETARDATION MALFORMATION SYNDROME; MICROCEPHALY; MULTIPLE MALFORMATION SYNDROME; NEUROLOGICAL COMPLICATION; PHENOTYPE; PHENYLKETONURIA; PREGNANCY; PRIORITY JOURNAL;

COHORT STUDIES; COOPERATIVE BEHAVIOR; FACE; FEMALE; HUMANS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NERVOUS SYSTEM MALFORMATIONS; PHENYLALANINE; PHENYLKETONURIA, MATERNAL; PREGNANCY;

EID: 0031046763     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19970303)69:1<89::AID-AJMG17>3.0.CO;2-K     Document Type: Article

References (27)

1. Bachman R, Schoen E, Backstrom M, Lee R, Williams S, Jurecki E (1993): Phenylalanine embryopathy in three siblings: implications of maternal diet therapy. The pediatric forum. Am J Dis Child 147:22-23.
2. Dent CE (1957): Relation of biochemical abnormality to development of mental defect in phenylketonuria. In: "Report of 23rd Ross Pediatric Research Conference." Columbus, OH: Ross Laboratories, p 32.
3. Dixon WJ (ed; 1990): "BMDP Statistical Software Manual," Vol 2. Berkeley, CA: University of California Press.
4. Dyer C, Philibotte T, Levy H, Cruz J (1995): Mechanisms of hypomyelination and gliosis in a genetic mouse model for phenylketonuria. J Neurochem 64(Suppl):S111.
5. Feingold M, Bossert WH (1974): Normal values for selected physical parameters: An aid to syndrome delineation. Birth Defects: Orig Art Ser 10(13).
6. Goodman R, Gorlin R (1983): "The Malformed Infant and Child." New York: Oxford University Press.
7. Kirby M, Miyagawa S (1990): The effects of high phenylalanine concentration on chick embryonic development. J Inner Metab Dis 13:634-640.
8. Kirkman HN (1982): Projections of a rebound in frequency of mental retardation from phenylketonuria. Appl Res Ment Retard 3: 319-328.
9. Koch R, Hanley W, Levy H, Matalon R, Rouse B, de la Cruz F, Azen C (1990): A preliminary report of the collaborative study of maternal phenylketonuria in the United States and Canada. J Inher Metab Dis 13:641-650.
10. Koch R, Levy H, Matalon R, Rouse B, Hanley W, Friedman E, Azen C, de la Cruz F (1993): The North American Collaborative Study of Maternal Phenylketonuria (PKU). Int Pediatr 8:89-96.
11. Lenke RR, Levy HL (1980): Maternal phenylketonuria and hyperphenylalaninemia: An international survey of the outcome of untreated and treated pregnancies. N Engl J Med 303:1202-1208.
12. Lipson AH, Yu JS, O'Halloran M, Williams R (1981): Alcohol and phenylketonuria. Lancet 1:717.
13. Lipson AH, Buehler B, Bartley J, Walsh D, Yu J, O'Halloran M, Webster W (1984): Maternal hyperphenylalaninemia fetal effects. J Pediatr 104:216-220.
14. Mabry CC, Denniston JC, Nelson TL, Choon DS (1963): Maternal phenylketonuria. A cause of mental retardation in children without metabolic defect. N Engl J Med 269:1404-1408.
15. McDonald D, Bode V, Dove W, Shedlovsky A (1990): Pah hph-5: A mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci USA 87:1965-1967.
16. Merlob P, Sivan Y, Reisner S (1984): Anthropometric measurements of the newborn infant. Birth Defects: Orig Art Ser 20(7):9,11,16,22.
17. Moore K (1973): The Face. In: "The Developing Human," 1st Ed. Philadelphia: W.B. Saunders Co., First Edition, p. 148.
18. Moore K (1988): "The Developing Human," 4th Ed. Philadelphia: W.B. Saunders Co., pp 286, 373.
19. Müller WD, Haidvogel M, Scheibenreiter S (1979): Phenylalanin- fetopathie bei Zwillingen einer nicht diagnostizierten phenylketonurischen Mutter. Klin Pädidiatr 191:609.
20. Nellhaus G (1968): Head circumference from birth to eighteen years: Practical composite international and interracial graphs. Pediatrics 41:106.
21. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P (1991): An update of the Swedish Reference Standards for weight, length, and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand 80:756-762.
22. Nora J, Nora A (1978): Presumed vulnerable period for teratogenic influence on cardiovascular development. Genetics and counseling in cardiovascular diseases. Springfield, IL: Charles C. Thomas, pp 131, 141.
23. Platt L, Koch R, Azen G, Hanley W, Levy H, Matalon R, Rouse B, de la Cruz F, Walla C (1992): Maternal phenylketonuria collaborative study, obstetric aspects and outcome: The first 6 years. Am J Obstet Gynecol 166:1150-1162.
24. Rouse B, Lockhart L, Matalon R, Azen C, Koch R, Hanley W, Levy H, de la Cruz F, Friedman E (1990): Maternal phenylketonuria pregnancy outcome: A preliminary report of facial dysmorphology and major malformations. J Inher Metab Dis 13:289-291.
25. SAS Institute, Inc. (1988): "SAS/STAT User's Guide," Release 6.03. Cary, NC: SA Institute, Inc., pp 1028.
26. Sadler T (1985): Head and Neck In: "Langman's Medical Embryology," 5th Ed. Baltimore: Williams and Wilkins, pp 295-298, 334-343.
27. Stevenson R, Huntley C (1967): Congenital malformations in offspring of phenylketonuric mothers. Pediatrics 40:33-15.